Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCT.
- DOI
- 10.3310/jwtr4127
- Published
- 2024 Aug
- Container
- Health technology assessment (Winchester, England)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3310/jwtr4127,
title = {Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCT.},
author = {Collinson F and Royle KL and Swain J and Ralph C and Maraveyas A and Eisen T and Nathan P and Jones R and Meads D and Min Wah T and Martin A and Bestall J and Kelly-Morland C and Linsley C and Oughton J and Chan K and Theodoulou E and Arias-Pinilla G and Kwan A and Daverede L and Handforth C and Trainor S and Salawu A and McCabe C and Goh V and Buckley D and Hewison J and Gregory W and Selby P and Brown J and Brown J and all the STAR investigators},
year = {2024},
journal = {Health technology assessment (Winchester, England)},
doi = {10.3310/jwtr4127},
url = {https://doi.org/10.3310/jwtr4127}
}RIS
TY - JOUR TI - Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCT. AU - Collinson F AU - Royle KL AU - Swain J AU - Ralph C AU - Maraveyas A AU - Eisen T AU - Nathan P AU - Jones R AU - Meads D AU - Min Wah T AU - Martin A AU - Bestall J AU - Kelly-Morland C AU - Linsley C AU - Oughton J AU - Chan K AU - Theodoulou E AU - Arias-Pinilla G AU - Kwan A AU - Daverede L AU - Handforth C AU - Trainor S AU - Salawu A AU - McCabe C AU - Goh V AU - Buckley D AU - Hewison J AU - Gregory W AU - Selby P AU - Brown J AU - Brown J AU - all the STAR investigators PY - 2024 JO - Health technology assessment (Winchester, England) DO - 10.3310/jwtr4127 UR - https://doi.org/10.3310/jwtr4127 ER -
APA
F, C., KL, R., J, S., C, R., A, M., T, E., P, N., R, J., D, M., T, M. W., A, M., J, B., C, K., C, L., J, O., K, C., E, T., G, A., A, K., L, D., C, H., S, T., A, S., C, M., V, G., D, B., J, H., W, G., P, S., J, B., J, B., & investigators, A. T. S. (2024). Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCT.. Health technology assessment (Winchester, England). https://doi.org/10.3310/jwtr4127
Source records
- pubmed · retrieved 2026-09-27T13:59:27.139Z